Inhibitory effects of nicotinamide on recombinant human interferon-gamma-induced intercellular adhesion molecule-1 (ICAM-1) and HLA-DR antigen expression on cultured human endothelial cells
- 1 January 1992
- journal article
- Published by Elsevier BV in Immunology Letters
- Vol. 31 (1), 35-39
- https://doi.org/10.1016/0165-2478(92)90007-b
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Inhibition of cytokine-induced MHC class II but not class I molecule expression on mouse islet cells by niacinamide and 3-aminobenzamideDiabetes, 1990
- Cytokines as communication signals between leukocytes and endothelial cellsImmunology Today, 1989
- Expression of an intercellular adhesion molecule, ICAM-1, by human thyroid cellsJournal of Endocrinology, 1989
- ICAM-1 a ligand for LFA-1-dependent adhesion of B, T and myeloid cellsNature, 1988
- Human T-Cell Clones from Autoimmune Thyroid Glands: Specific Recognition of Autologous Thyroid CellsScience, 1985
- ABERRANT EXPRESSION OF HLA-DR ANTIGEN ON THYROCYTES IN GRAVES' DISEASE: RELEVANCE FOR AUTOIMMUNITYThe Lancet, 1983
- Ia expression by vascular endothelium is inducible by activated T cells and by human gamma interferon.The Journal of Experimental Medicine, 1983
- Preventive and therapeutic effects of large-dose nicotinamide injections on diabetes associated with insulitis. An observation in nonobese diabetic (NOD) miceDiabetes, 1982
- Endothelial cell presentation of antigen to human T cellsHuman Immunology, 1981
- Poly(ADP-ribose) levels in carcinogen-treated cellsNature, 1979